Skip to contentViking Global Opportunities Portfolio GP LLC — Urovant Sciences Ltd. insider: 5 transactions · InsiderLensViking Global Opportunities Portfolio GP LLC
- 10% owner at RayzeBio, Inc. · on record since Sep 21, 2023
- 10% owner at LABRANCHE & CO INC · on record since Mar 20, 2024
- 10% owner at APi Group Corp · on record since Mar 7, 2024
- 10% owner at TASER INTERNATIONAL INC · on record since Jul 13, 2016
- 10% owner at Arbutus Biopharma Corp · on record since Jul 13, 2016
- 10% owner at Glori Energy Inc. · on record since Jun 7, 2024
- 10% owner at TIC Solutions, Inc. · on record since Feb 14, 2025
- 10% owner at Myovant Sciences Ltd. · on record since Oct 26, 2016
- Former 10% Owner at Editas Medicine, Inc. · on record since Feb 9, 2016
- 10% owner at Editas Medicine, Inc. · on record since Feb 8, 2016
- 10% owner at FIGS, Inc. · on record since Jun 7, 2021
- 10% owner at GENENTECH INC · on record since Sep 23, 2021
- 10% owner at Urovant Sciences Ltd. · on record since Sep 26, 2018
- 10% owner at BridgeBio Pharma, Inc. · on record since Jun 28, 2019
- 10% owner at ADAPTEC INC · on record since Jun 26, 2019
- Former 10% Owner at Urovant Sciences Ltd. · on record since Jul 12, 2019
- Former 10% Owner at TASER INTERNATIONAL INC · on record since Jul 12, 2019
- Former 10% Owner at Arbutus Biopharma Corp · on record since Jul 12, 2019
- Former 10% Owner at Myovant Sciences Ltd. · on record since Jul 12, 2019
- 10% owner at ADVANCED PHOTONIX INC · on record since Apr 28, 2020
- 10% owner at Zentalis Pharmaceuticals, Inc. · on record since Apr 8, 2020
- 10% owner at Inhibrx Biosciences, Inc. · on record since Aug 28, 2020
- 10% owner at Rallybio Corp · on record since Jul 29, 2021
- 10% owner at 4D Molecular Therapeutics, Inc. · on record since Dec 17, 2020
- 10% owner at PROCEPT BioRobotics Corp · on record since Sep 21, 2021
- 10% owner at Roivant Sciences Ltd. · on record since Oct 1, 2021
- 10% owner at Amylyx Pharmaceuticals, Inc. · on record since Jan 13, 2022
- 10% owner at Frazier Lifesciences Acquisition Corp · on record since Nov 25, 2022
Insider trading activity of Viking Global Opportunities Portfolio GP LLC
- Transactions on record
- 5
- since Oct 17, 2017
- Open-market buys
- 4
- $10.2M
- Open-market sells
- 0
- Companies traded
- 3
- last filing Jun 11, 2019
Figures computed from official regulatory filings — methodology.
Companies where Viking Global Opportunities Portfolio GP LLC has traded
Track record of Viking Global Opportunities Portfolio GP LLC
Statistical track record
Free- Open-market buys
- 5
- Last buy
- Jun 11, 2019
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of Viking Global Opportunities Portfolio GP LLC
Co-insiders of Viking Global Opportunities Portfolio GP LLC
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
4D Molecular Therapeutics, Inc. +13
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 11, 2019 | Buy | 7,500 | 8.35 USD | $62.6K | SEC |
| Jun 11, 2019 | Buy | 7,189 | 8.58 USD | $61.7K | SEC |
| Jun 11, 2019 | Buy | 6,649 | 7.97 USD | $53K | SEC |
| Mar 19, 2019 | Buy | 6,666,667 | 1.50 USD | $10M | SEC |
| Oct 17, 2017 | BuyD | 500,000 | 100.00 USD | $50M | SEC |